News Briefs

FDA panel: benefits of COVID-19 vaccine for ages 5-11 outweigh risks
October 29, 2021 - 12:44 pm

A federal vaccine panel said Tuesday the benefits of the Pfizer-BioNTech COVID-19 vaccine for children ages 5-11 years outweigh the potential risks, although some expressed hesitation in recommending it for all children in this age group.

Members of the Food and Drug Administration’s (FDA’s) Vaccines and Related Biological Products Advisory Committee said they want to protect children from COVID-related infections, hospitalizations and deaths as well as disruptions to their education. However, the risk of myocarditis, though rare, gave some pause.

Source: American Academy of Pediatrics

News Briefs


What pandemic Christmas of 1918 looked like

We take a trip back in time with Smithsonian Magazine to uncover the social and political issues affecting pandemic Christmas of 1918.

Twitter Handle

Copyright © 2021 I Daily Remedy